Literature DB >> 11489925

Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena.

R V Iozzo1, J D San Antonio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489925      PMCID: PMC209371          DOI: 10.1172/JCI13738

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  43 in total

Review 1.  Matrix proteoglycans: from molecular design to cellular function.

Authors:  R V Iozzo
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

2.  Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope.

Authors:  W Göhring; T Sasaki; C H Heldin; R Timpl
Journal:  Eur J Biochem       Date:  1998-07-01

3.  Transcriptional silencing of perlecan gene expression by interferon-gamma.

Authors:  B Sharma; R V Iozzo
Journal:  J Biol Chem       Date:  1998-02-20       Impact factor: 5.157

4.  A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells.

Authors:  M Mathiak; C Yenisey; D S Grant; B Sharma; R V Iozzo
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

5.  Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding.

Authors:  Z Chang; A Choon; A Friedl
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

6.  Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action.

Authors:  S Clasper; S Vekemans; M Fiore; M Plebanski; P Wordsworth; G David; D G Jackson
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

7.  Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165.

Authors:  S Gengrinovitch; B Berman; G David; L Witte; G Neufeld; D Ron
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

8.  Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA.

Authors:  R Adatia; A Albini; S Carlone; D Giunciuglio; R Benelli; L Santi; D M Noonan
Journal:  Ann Oncol       Date:  1997-12       Impact factor: 32.976

9.  A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.

Authors:  F Czubayko; E D Liaudet-Coopman; A Aigner; A T Tuveson; G J Berchem; A Wellstein
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

10.  Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.

Authors:  B Sharma; M Handler; I Eichstetter; J M Whitelock; M A Nugent; R V Iozzo
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

View more
  128 in total

Review 1.  Heparan sulfate: lessons from knockout mice.

Authors:  E Forsberg; L Kjellén
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

3.  Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

Authors:  Simone A Joosten; Mieneke G A van Dixhoorn; Maria C Borrias; Hallgrimur Benediktsson; Peter A van Veelen; Cees van Kooten; Leendert C Paul
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

4.  Biosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-O-sulphotransferase-2 having different expression patterns and properties.

Authors:  Hiroko Habuchi; Goichiro Miyake; Ken Nogami; Asato Kuroiwa; Yoichi Matsuda; Marion Kusche-Gullberg; Osami Habuchi; Masayuki Tanaka; Koji Kimata
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

5.  Adipose tissue progenitor cells directly interact with endothelial cells to induce vascular network formation.

Authors:  Stephanie Merfeld-Clauss; Nagesh Gollahalli; Keith L March; Dmitry O Traktuev
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

Review 6.  Role of heparan sulfate in sexually transmitted infections.

Authors:  Vaibhav Tiwari; Erika Maus; Ira M Sigar; Kyle H Ramsey; Deepak Shukla
Journal:  Glycobiology       Date:  2012-07-06       Impact factor: 4.313

7.  Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1.

Authors:  Astri J Meen; Inger Øynebråten; Trine M Reine; Annette Duelli; Katja Svennevig; Gunnar Pejler; Trond Jenssen; Svein O Kolset
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

8.  Novel human-derived extracellular matrix induces in vitro and in vivo vascularization and inhibits fibrosis.

Authors:  Marc C Moore; Vittoria Pandolfi; Peter S McFetridge
Journal:  Biomaterials       Date:  2015-02-11       Impact factor: 12.479

9.  The association of arylendosulfatase 1 (SULF1) gene polymorphism with recurrent miscarriage.

Authors:  Mahnaz Zahraei; Mohammad Hasan Sheikhha; Seyed Mehdi Kalantar; Nasrin Ghasemi; Tahere Jahaninejad; Shokohe Rajabi; Hemn Mohammadpour
Journal:  J Assist Reprod Genet       Date:  2013-12-10       Impact factor: 3.412

Review 10.  Mechanisms of heparanase inhibitors in cancer therapy.

Authors:  Benjamin Heyman; Yiping Yang
Journal:  Exp Hematol       Date:  2016-08-26       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.